Sign in

Wei-Tse Hsu

@weitse-hsu.bsky.social
88 followers 309 following 10 posts

- Postdoc in Drug Design at Oxford Biochemistry (Biggin Lab). - Ph.D. from the Shirts Group at CU Boulder. - Keen on compchem, deep learning & education. - Rookie runner. - Originally from Taiwan. - Check my MD tutorials: weitsehsu.com

PostsRepliesMedia
Reposted by Wei-Tse Hsu
Joe Greener @jgreener64.bsky.social · 07/08/2026
Happy to play a small part in this perspective led by @andreasbender.bsky.social on where AI is in drug discovery, and what we should do in future. www.nature.com/articles/s41... Free link: rdcu.be/fyr77
nature.com
Artificial intelligence in drug discovery — what it is, where we stand and the path forward - Nature Reviews Drug Discovery
Applications of artificial intelligence (AI) in drug discovery have attracted high interest in recent years, but evidence for clinically relevant impact so far is limited. This Perspective discusses p...
041
Wei-Tse Hsu @weitse-hsu.bsky.social · 06/08/2026
More importantly, MDArena is designed to be easily extended and tested with new models and agents, and we are already preparing many more tasks drawn from ongoing research for future releases. Please check out the repo and stay tuned for our next release! 🚀 github.com/weitse-hsu/M...
github.com
GitHub - weitse-hsu/MDArena: MDArena is an open benchmark for evaluating AI agents on molecular dynamics (MD) workflows.
MDArena is an open benchmark for evaluating AI agents on molecular dynamics (MD) workflows. - weitse-hsu/MDArena
000
Wei-Tse Hsu @weitse-hsu.bsky.social · 06/08/2026
We evaluated 6 model–harness configurations, including GPT-5.5, Gemini 3.5 Flash, and Gemini 3.1 Pro. The strongest solved about half of the tasks. With several major frontier-model releases in recent weeks, we are now testing GPT-5.6, Claude Opus-5, and more, with updated results coming soon. 🚀
100
Wei-Tse Hsu @weitse-hsu.bsky.social · 06/08/2026
🧬 In the current release, MDArena contains 50 tasks across 29 molecular systems, spanning system preparation, parameterization, free-energy methods, enhanced sampling, and analysis. Each task runs in a reproducible container and is graded for both scientific correctness and workflow quality.
110
Wei-Tse Hsu @weitse-hsu.bsky.social · 06/08/2026
🚨 Can AI reliably handle real-world, multi-step MD workflows comp chemists face every day? With Nithishwer Mouroug Anand and colleagues in the Biggin Lab @philbiggin.bsky.social @oxfordbiochemistry.bsky.social, we built MDArena from problems in active research projects. arxiv.org/abs/2608.02642
arxiv.org
MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort...
262
Reposted by Wei-Tse Hsu
Open Force Field @openforcefield.org · 05/08/2026
It's exciting to see real users testing agentic workflows that make use of our models and tools. Thanks to the Biggin lab for publicizing these results and showing the work that still needs to be done!
041
Reposted by Wei-Tse Hsu
Phil Biggin @philbiggin.bsky.social · 05/08/2026
Latest preprint where we pooled our sim experiences to create "MDArena" for AI agents trying to automate MD simulation and analysis. Great work led by Nithishwer Mouroug Anand and @weitse-hsu.bsky.social and thanks to all lab members! @oxfordbiochemistry.bsky.social arxiv.org/abs/2608.02642
arxiv.org
MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort...
0156
Reposted by Wei-Tse Hsu
Phil Biggin @philbiggin.bsky.social · 20/03/2026
Happy to see our work on SLCO2A1 with @smlea.bsky.social, Nakanishi and Newstead labs out now. Important insight into how prostaglandin and many drugs are transported. Hats off to @weitse-hsu.bsky.social for computational work! @oxfordbiochemistry.bsky.social www.nature.com/articles/s41...
nature.com
Structural basis for prostaglandin and drug transport via SLCO2A1
Nature Communications - SLCO2A1 (also known as OATP2A1) is responsible for the transport of eicosanoids, including prostaglandins (PGs), as well as of a subset of nonsteroidal anti-inflammatory...
13011
Reposted by Wei-Tse Hsu
Cole Group @colegroupncl.bsky.social · 27/01/2026
Now out in JACS! 🎉 : "Computing Solvation Free Energies of Small Molecules with Experimental Accuracy"! It's been a pleasure to collaborate on this with Harry Moore (@jhmchem.bsky.social) & Gábor Csányi pubs.acs.org/doi/10.1021/...
1298
Reposted by Wei-Tse Hsu
Stephanie Wankowicz @stephanieaw.bsky.social · 21/01/2026
New Preprint!! We show that binding entropy can be quantitatively predicted from crystallographic ensemble models, accounting for both protein conformational entropy and solvent entropy! www.biorxiv.org/content/10.6...
13914
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
🚀 Bottom line: With careful filtering, co-folding predictions can indeed teach ML about binding affinity. 👉 Read the full JCIM paper: pubs.acs.org/doi/full/10.... Work with Aniket Magarkar @boehringerglobal.bsky.social and @philbiggin.bsky.social @ox.ac.uk (6/6)
pubs.acs.org
Can AI-Predicted Complexes Teach Machine Learning to Compute Drug Binding Affinity?
We evaluate the feasibility of using co-folding models for synthetic data augmentation in training machine learning-based scoring functions (MLSFs) for binding affinity prediction. Our results show th...
021
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
🔎 SI highlights: - AEV-PLIG beats Boltz-2 in 4 target classes in the FEP benchmark (loses 1, ties 6); both are competitive with FEP+ in some cases. - ipLDDT & ligand pLDDT are also effective filters; pTM, PAE, PDE are not - Boltz confidence seems to generalize better than its structure module (5/6)
110
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
❓ Are co-folding predictions good enough to train scoring functions? 👉 Yes — with careful filtering. We see no performance difference b/w models trained on: - experimental structures - corresponding co-folding predictions This holds across AEV-PLIG, EHIGN, and RF-Score. (4/6)
100
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
❓ When can we trust a co-folding prediction? 👉 From reproducing HiQBind with Boltz-1x, a few simple heuristics are recommended high-quality cofolding augmentation: 1️⃣ single-chain systems 2️⃣ Boltz confidence > 0.9 3️⃣ train–test similarity > 60% (3/6)
110
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
❓ How much can data augmentation actually improve scoring? 👉 Short answer: only if the added data are high-quality. Adding BindingNet v1 clearly improved performance, but v2 did not—despite being 10x larger—due to its substantially lower quality. Quality beats quantity. (2/6)
110
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
📢 Can AI-Predicted Complexes Teach Machine Learning to Compute Drug Binding Affinity? In our recent JCIM work, we tested whether co-folding models can be used for data augmentation for training ML-based scoring functions (SFs). We asked 3 simple but critical questions. 👇 (1/6)
161